OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

REGISTERED CHARITY NUMBER: 1164374

Report of the Trustees and Unaudited Financial Statements for the Year Ended 31 December 2025 for Action Bladder Cancer UK

Action Bladder Cancer UK

Contents of the Financial Statements for the Year Ended 31 December 2025

Page
Report of the Trustees 1 to 8
Independent Examiner's Report 9
Statement of Financial Activities 10
Balance Sheet 11
Notes to the Financial Statements 12 to 17
Detailed Statement of Financial Activities 18

Action Bladder Cancer UK

Report of the Trustees

for the Year Ended 31 December 2025

The trustees present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of the Statement of Recommended Practice (SORP) 'Accounting and Reporting by Charities' issued in 2019.

REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number

1164374

Principal address

6 Trull Farm Buildings Tetbury Gloucestershire GL8 8SQ

Trustees

Roger Kockelbergh (Chair) Jeremy Crew Paula Allchorne Allen Knight Professor Rik Bryan Dr Mark Page Dr Peter Harper (Vice Chair) Caroline Raw Jenny Akins Alexandra Colquhoun

Independent Examiner

Woodlands Grange Woodlands Road Bradley Stoke Bristol BS32 4JY

Administrators

The Trust Partnership 6 Trull Farm Buildings Tetbury Gloucestershire GL8 8SQ

Page 1

Action Bladder Cancer UK

for the Year Ended 31 December 2025

Report of the Trustees

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

Action Bladder Cancer UK was constituted as a Charitable Incorporated Organisation on 9[th ] July 2015 and became registered charity on 12 November 2015. The Charity is governed by its present constitution which was adopted on 9[th ] July 2015. The Charity had originally been established as Action on Bladder Cancer in 2009.

Recruitment and appointment of new trustees

Where there is a requirement for new trustees, these would be identified and appointed by the current Trustees and elected by the members of Action Bladder Cancer UK at a General Meeting. The chair of Trustees is responsible for the induction of any new Trustee which involves a briefing on a Trustee's responsibilities, the governing document and policies, administrative procedures, the history of the Charity and the philosophical approach of the Charity. All Trustees provide their services as trustees for free.

Key management personnel

The Trustees consider that they, and the Clerk to the Trustees, comprise the key governance of the Charity. The Chief Executive manages the Charity and is in charge of directing and controlling, running and operating the Charity on a day to day basis, including income generation, management and development of the Charity. The Trustees receive no remuneration. The Chief Executive also manages the ABC UK core staff team including patient support staff , project staff and freelance staff.

Risk management

The Trustees have a duty to identify and review the risks to which the Charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. The Trustees have identified a register of risks which they review annually.

The Trustees have reviewed the risk register, the risks identified and the processes to manage or mitigate any risk. The Trustees are satisfied that all potential major risks have been considered and a mitigation management process identified. As part of this process, some of the key agreed actions are:

In looking to the future, the Trustees will continue to monitor the risks associated with its investments and continue to be vigilant as to other risks that might be associated with a grant making charity.

Page 2

Action Bladder Cancer UK

Report of the Trustees for the Year Ended 31 December 2025

OBJECTIVES AND ACTIVITIES

Objectives and aims

The objects of the Charity as defined by the constitution are the relief of sickness and preservation of health in particular but not exclusively by:

Public benefit

The T public benefit when reviewing the C policy for the year and that they have complied with the duty in section 17(5) of the 2011 Charities Act.

The trustees are satisfied that all charitable activities during the year are for the benefit of the public and the benefits of each and every activity are clearly identifiable.

Charitable activities

The Trustees normally meet four times a year to agree funding priorities, charitable activities, strategy and policy.

The Trust Partnership handle the central administration for Action Bladder Cancer UK and also look after the financial affairs of the Charity on a day to day basis.

The Charity is supported by an active network of core staff, project staff and volunteers, who help deliver programmes and projects, set up support groups and provide patient viewpoint on all new projects and materials produced by the Charity. The Charity is also actively assisted in its work by the involvement of specialist clinicians, researchers and nurses.

Page 3

Action Bladder Cancer UK

Report of the Trustees

for the Year Ended 31 December 2025

ACHIEVEMENT AND PERFORMANCE

Action Bladder Cancer UK continues to have a major impact with significant achievements and successful development of new programmes and projects. We have expanded our programmes of work significantly in recent years, and will be continuing to build on this growth. Our core team continue to deliver our programmes with great commitment, supported by our volunteer networks, which continue to grow and have increased significantly in 2025. We have a planned strategy for continued growth in 2025 and onwards. ABC UK Trustees are a highly valued source of expertise and commitment and represent bladder cancer patients, clinicians, nursing and cancer research. We thank our Trustees for their continued commitment and work as members of the board in 2025, there are currently 10 Trustees on the board.

Trustees were pleased that ABC UK continues to develop our vital work in 2025, and also to build on our programmes, including new activity launched in 2025. We have continued to grow our Health Professional Education Programme by developing resources and an annual programme of events, both for primary care and specialist nurses. We continue to expand our core activity to support patients, raise awareness, and our grants funding programmes. The need for our work is greater than ever.

areas of activity are: improving awareness of the symptoms of bladder cancer and the issues relating to an under-researched and under-funded condition and the unmet needs of patients, improving patient support, improving outcomes for bladder cancers patients, providing learning programmes and resources on bladder cancer for health professionals, and funding and encouraging research into bladder cancer. A summary of key activity is below.

AWARENESS RAISING

We work to raise the profile of bladder cancer and the unmet needs of patients across the UK:

PATIENT SUPPORT

Patient Information and Direct Patient Support

SUPPORTING AND EDUCATING HEALTH PROFESSIONALS

ABC UK works closely with health professionals. There is a lack of learning opportunities for health professionals regarding bladder cancer. ABC UK are working to improve this by:

Primary Care Education

Raising awareness amongst GPs to improve early diagnosis of bladder cancer is a core activity for ABC UK.

Nurse Education Programme

Page 4

Action Bladder Cancer UK

for the Year Ended 31 December 2025

Report of the Trustees

RESEARCH

The significant lack of research investment into bladder cancer has a direct impact on the development of new treatments, poor patient outcomes, and the patient experience. We work to improve research into bladder cancer by:

  - Improving Outcomes for Patients Programme (IOPP).

ABC UK Improving Outcomes for Patients Programme - IOPP and ABC UK Nursing Awards

The 2024/2025 round of IOPP grants, which were awarded in late Spring 2025, again provided some excellent applications, and we were also pleased to award the third The high quality of these grant applications continues to impress, and also to demonstrate the importance of helping to advance much-needed research into bladder cancer.

The 2025/2026 grant rounds for both IOPP and the ABC UK Nursing Awards launched in November 2025 for grants to be awarded in May 2026.

PUTTING THE PATIENT PERSPECTIVE

We continue to support, provide patient input to, and publicise, clinical trials for bladder cancer treatments, and assist with patient recruitment and provide feedback and input into trial development. We also contribute to consultations and expert roundtables and provide patient briefing and viewpoint to many within the bladder cancer sector. We regularly attend conferences, seminars and study days for health professionals - such as urologists, cancer nursing specialists and urology nurses - and provide patient representatives for advisory boards and research panels and carry out our own research.

POLICY

We are regular contributors to NICE, SMC, PHE, NIHR consultations relating to bladder cancer. Priority areas of ABC UK policy activity in 2025 and on-going includes:

Our work is only possible because of the enormous commitment and generosity of our many supporters those who donate, who fundraise or support our work in memory of a loved one. We would like to thank the many members of the public who raise much needed funds to support our work and help us to raise awareness. Many individuals show enormous commitment, and initiative, to supporting ABC UK and our much-needed work and we are extremely grateful to you all.

We would also like to thank the funders who have helped to support our work, as well as our corporate supporters (both those with a direct interest in bladder cancer and others).

Thank you to our wonderful team - the ABC UK staff team have continued to deliver much-needed support to patients with great commitment and professionalism and to develop and drive our new projects and programmes of work in 2025. We look forward to welcoming new members of the team in 2026.

THANK YOU

Page 5

Action Bladder Cancer UK

Report of the Trustees

for the Year Ended 31 December 2025

FINANCIAL REVIEW

During the year ended 31st December 2025 the charity received income on an accruals basis totaling £175,074 (2024: £341,314 with regular oversight from Trustees at meetings.

Total expenditure for the period, including fundraising, operational and charitable expenditure, was £271,019 (2024: £267,861). Net expenditure on an accruals basis for the period was £95,945 (2024: Net income £73,453). At the end of the financial year unrestricted reserves were £378,671 (2024: £474,616). This allows for 18 months of core running costs with the remainder contributing to a planned research fund.

Whilst income reduced from 2024, this was mainly due to a delay in an expected funding commitment, which has now been confirmed for Q1 2026. ABC UK have been pleased to see income maintain a healthy level in 2026 with funding commitments looking very healthy.

We continue to have valued corporate partners. We have also been able to engage new funding supporters and are working to increase our funder base even further for 2026.

We are pleased to have been able to launch new projects and develop our existing, very successful, programmes of activity in 2025. This learning is feeding into our planned strategy review in 2026 for future development in 2026 and beyond. . We continue to be delighted with the successful development of our health professional education programme, the growth of our patient support service, events and support resources. The Trustees continue to be very pleased with our growing impact and successful programmes of work.

Reserves policy

It is the policy of the trustees to hold sufficient funds in hand to cover grant commitments and expenses for the current financial year and to maintain an appropriate budget for future years to ensure that they could cover longer term commitments. The Trustees were pleased that the income levels of 2025 ensured that the funds in hands were able to be maintained and increased.

The commitments and liabilities within one year totaled £36,407 as at 31 December 2025 (2024: £21,158). The Trustees considered that the cash balance of £412,949 as at 31 December 2025 was sufficient to cover these commitments and future financial commitments such as payroll and identified areas of increased expenditure for 2026 including building a research fund, new staff and project roles and delivering programmes of activity.

Going Concern

The Trustees of the charity believe that there are no material uncertainties that may cast significant doubt about the ability of the Charity to continue as a going concern.

Page 6

Action Bladder Cancer UK

Report of the Trustees for the Year Ended 31 December 2025

FUTURE DEVELOPMENTS

The charity has continued to expand our activity in 2025, building on our existing work and piloting new projects. The Board have been delighted with the growth in our impact and the development of the Charity.

Our excellent, and deeply committed, team continues to deliver our programmes as well as help us innovate and be responsive to patients and health professionals. We look forward to a specialist urology nurse joining our patient support team early in 2026. Our network of volunteers has grown considerably, and we will be continuing to build on this, and look forward to welcoming more patients and family members to the ABC UK team to helpto deliver our work, raise funds and awareness of bladder cancer.

Our network of bladder cancer patient volunteers has increased substantially these patients help deliver our programmes, run events, raise awareness and directly feed into all of our work. The ABC UK Patient Focus Group continues to be very active, providing input on new materials, programmes, research and helping us to develop new ideas.

The ABC UK Nurse Education Programme goes from strength to strength and is providing highly effective learning opportunities for specialist cancer and urology nurses. It also enables us to build a large community of specialist nurses, and strong networks in hospitals and Trusts across the UK. We are excited about the potential of this Programme for further development.

Our work to improve early diagnosis of bladder cancer has included the ABC UK online learning module for GPs. This is proving very successful, and we shall be widening our marketing of this, and other primary care resources, in 2026 to reach more GPs and community health networks.

We are proud that we are meeting a real unmet need for an education programme on bladder cancer for health professionals, and one which has considerable potential for the future.

Our work to support bladder cancer patients is the bedrock of everything we do. We have new, and updated, resources and have been running events and continue to expand our network of patient support groups across the UK.

We have expanded our awareness raising activity with new materials, both online and print. We attended many awareness events across the UK during 2025, and continued our programme of online workplace sessions. We are working to expand this activity by reaching more widely into the community.

Our Improving Outcomes for Patients grants Programme (IOPP) continues to grow in recognition and impact. The quality of applications are of high quality, and we are particularly pleased that some are in new, and exciting, areas of bladder cancer research. ABC UK feels that the impact of these grants is considerable, and is addressing a real need in the research community of providing grant funding for bladder cancer research, particularly for very valuable early stage research which can then enable wider research work. We are proud of the impact of our grant funding.

The Board and the ABC UK team look forward to 2026 to building on our successes, consolidate the future of the charity, and, to launch further new activity ].

ABC UK makes a big impact, and we are excited and committed to building on this in 2026.

Page 7

Action Bladder Cancer UK

for the Year Ended 31 December 2025

Report of the Trustees

STATEMENT OF TRUSTEES RESPONSIBILITIES

The Trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Generally Accepted Accounting Practice.

The law applicable to charities in England and Wales, the Charities Act 2011, Charity (Accounts and Reports) Regulations 2019 and the provisions of the trust deed requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing those financial statements, the Trustees are required to

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2019 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charity's website.

ON BEHALF OF THE BOARD:

............................................. Roger Kockelbergh (Chair)

Date:

Page 8

Independent Examiner's Report to the Trustees of Action Bladder Cancer UK

Independent examiner's report to the trustees of Action Bladder Cancer UK

I report to the charity trustees on my examination of the accounts of the Charity for the year ended 31 December 2025.

Responsibilities and basis of report

As the charity's trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 20 Act').

I report in respect of my examination of the accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5) (b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Charity as required by Section 130 the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Matthew Dobbins FCA

Dunkley's Woodlands Grange Woodlands Lane Bradley Stoke Bristol BS32 4JY Date: .............................................

Page 9

The notes form part of these financial statements

Action Bladder Cancer UK

Statement of Financial Activities for the Year Ended 31 December 2025

Notes
Income
Donations
2
Fundraising events
Interest received
Total income
EXPENDITURE
Costs of generating funds
3
Costs of generating voluntary income
Costs of generating sponsorship income
Costs of fundraising events
Charitable activities
Educating the public/awareness raising
4
Patient support
4
Improving outcomes
4
Total expenditure
NET EXPENDITURE
Net movement in funds
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD
Year
Ended
Year
Ended
31.12.25
31.12.24
Unrestricted
Total
Total
funds
Funds
Funds
£
£
£
125,229
125,229
286,239
47,306
2,539
47,306
2,539
52,612
2,463
175,074
175,074
341,314
4,131
4,131
3,152
11,922
11,922
9,096
3,653
3,653
10,265
19,706
19,706
22,513
77,124
77,124
65,070
136,911
136,911
130,019
37,278
37,278
50,259
251,313
251,313
245,348
271,019
271,019
267,861
(95,945)
(95,945)
73,453
(95,945)
(95,945)
73,453
474,616
474,616
401,163
378,671
378,671
474,616

Page 10

The notes form part of these financial statements

Action Bladder Cancer UK

Balance Sheet At 31 December 2025

Notes
CURRENT ASSETS
Debtors
9
Cash at bank
CREDITORS
Amounts falling due within one year
10
NET CURRENT ASSETS
CREDITORS
Amounts filling due after more than one year
11
NET ASSETS
FUNDS
12
Unrestricted funds
TOTAL FUNDS
Unrestricted
funds
£
6,004
412,949
31.12.25
31.12.24
Total
Total
funds
Funds
£
£

6,004
3,176

412,949
510,744
418,953
36,407

418,953
513,920

36,407
21,158
382,546
382,546
492,762
3,875 3,875
18,146

378,671
474,616
378,671
378,671
474,616
378,671
474,616

The financial statements were approved by the Board of Trustees on and were signed on its behalf by:

Roger Kockelbergh (Chair)

Jeremy Crew (Treasurer)

Page 11

The notes form part of these financial statements

Action Bladder Cancer UK

Notes to the Financial Statements for the Year Ended 31 December 2025

1. ACCOUNTING POLICIES

Accounting convention

These accounts have been prepared for the twelve-month period to 31[st] December 2025. The accounts have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant accounting policies below or the notes to these accounts. The accounts have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP FRS 102) 2019, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011. The charity constitutes a public benefit entity as defined by FRS 102. The accounts are presented in sterling and are rounded to the nearest pound.

Critical accounting estimates and areas of judgement

Preparation of the financial statements requires the trustees to make significant judgements and estimates. The trustees do not consider that there are any sources of estimation uncertainty or any key judgements made in the preparation of the financial statements.

Assessment of going concern

The trustees have assessed whether the use of the going concern assumption is appropriate in preparing these financial statements. The trustees have made this assessment in respect to a period of one year from the date of approval of these financial statements. The trustees of the charity have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the charity to continue as a going concern. The trustees are of the opinion that the charity will have sufficient resources to meet its liabilities as they fall due.

Income

All income is included on the Statement of Financial Activities when the charity is legally entitled to the income, it is probable that it will be received and the amount can be quantified with reasonable accuracy.

Donated facilities - where the organisation is given facilities and services for its own use which it would otherwise have purchased, these are included in the organisation's accounts as income and expenditure when received, provided the value of the gift can be measured reliably.

Expenditure

Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Expenditure on grants is recorded once the charity has made an unconditional commitment to pay the grant and this is communicated to the beneficiary or the grant has been paid, whichever is earlier. Grants offered subject to conditions which have not been met at the period end date are noted as a commitment but not accrued as expenditure. Should circumstances arise where the grant is repayable, this is accounted for at the point when the grant is received. If this is after the balance sheet date and known about it is reflected in the accounts as a post balance sheet event.

Debtors

Debtors are recognised at their settlement amount, less any provision for non-recoverability. Prepayments are valued at the amount prepaid. They have been discounted to the present value of the future cash receipt where such discounting is material.

Cash at bank and in hand

Cash at bank and in hand represents such accounts and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.

Page 12

Action Bladder Cancer UK

Notes to the Financial Statements

for the Year Ended 31 December 2025

Creditors and provisions

Creditors and provisions are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Creditors and provisions are recognised at the amount the charity anticipates it will pay to settle the debt. They have been discounted to the present value of the future cash payment where such discounting is material.

Taxation and Value Added Tax

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Statement of cash flows

The financial statements do not include a statement of cash flows because the charity is exempt from the requirement to prepare such a statement under the Charities SORP FRS 102.

2. DONATIONS

Donations
Legacies
Gift Aid
Grants
Year Ended
Year Ended
31.12.25
31.12.24
£
£
101,576
95,107
11,000
105,000
12,653
11,132
-
75,000
125,229
286,239

Page 13

Action Bladder Cancer UK Notes to the Financial Statements - continued for the Year Ended 31 December 2025

3. COSTS OF GENERATING FUNDS

sts of generating voluntary income
sts of generating sponsorship income
sts of fundraising events
CHARITABLE ACTIVITIES
ucating the public/awareness raising
tient support
proving outcomes
vernance costs (note 6)
Year Ended
Year Ended
31.12.25
31.12.24
£
£
4,131
3,152
11,922
9,096
3,653
10,265
19,706
22,513
Year Ended
Year Ended
31.12.25
31.12.24
£
£
74,240
63,570
130,002
125,868
36,577
49,888
10,494
6,022
251,313
245,348

Page 14

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

Action Bladder Cancer UK

5. GOVERNANCE COSTS

Accountancy and book-keeping
Incidental expenses
Independent examination
Secretariat
Insurance
6. NET INCOME
Net resources are stated after charging:
Independent examination fees
7. STAFF COSTS AND EMOLUMENTS
Salaries and fees
Social Security costs
Pension
Homeworking costs
Year Ended
Year Ended
31.12.25
31.12.24
£
£
2,872
1,658
284
314
1,746 1,116
5,153
2,538
439
396
10,494 6,022
Year Ended
Year Ended
31.12.25
31.12.24
£
£
1,746
1,116
Year Ended
Year Ended
31.12.25
31.12.24
£
£
87,125
92,402
1,949
4,139
3,981
4,125
702
1,734
93,757
102,400

There were no employees whose emoluments as defined for taxation purposes amounted to over £60,000 in the period. The average number of employees analysed by function was:

2025 2024
Management and Administrative staff 3.0 3.0

The average number of employees, calculated on a full-time equivalent basis was 2.3 (2024: 2.3). There was 1 full-time (2024: 1) and 2 part-time (2024: 2) members of staff employed during the year.

8

There were no trustees' remuneration or other benefits for the year ended 31 December 2025.

Trustees' Expenses

Trustees' travel expenses paid for the year ended 31 December 2025 totaled £401 (2024: £nil paid to no Trustees). Speaker fees amounting to £256 were paid to one Trustee in the year (2024: £500).

The trustees consider that they, and the Clerk to the trustees, comprise the key management of the charity in charge of directing and controlling, running and operating the charity on a day to day basis. The trustees receive no remuneration. During this period the Charity has employed a full time Head of Fundraising to support the income generation and development of the charity.

Page 15

Action Bladder Cancer UK

for the Year Ended 31 December 2025

Notes to the Financial Statements - continued

9. DEBTORS AND PREPAYMENTS

**9. ** DEBTORS AND PREPAYMENTS
Year Ended Year Ended
31.12.25 31.12.24
£ £
Other Debtors 4,673 1,163
Prepayments 1,331 2,013
6,004 3,176
10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Year Ended Year Ended
31.12.25 31.12.24
£ £
Other creditors 7,605 7,497
Deferred income 26,726 11,945
Accruals 2,076 1,716
36,407 21,158
11. CREDITORS: AMOUNTS FALLING IN MORE THAN ONE YEAR
Year Ended Year Ended
31.12.25 31.12.24
£ £
Deferred income 3,875 18,146
12.
MOVEMENT IN FUNDS

MOVEMENT IN FUNDS
At 31.12.24 Income Expenditure Net movement
in funds
At 31.12.25
£ £ £ £ £
Unrestricted funds
General fund 474,616 175,074 (271,019) (95,945) 378,671
TOTAL FUNDS 474,616 175,074 (271,019) (95,945) 378,671
ANALYSIS OF NET ASSETS BETWEEN FUNDS
Unrestricted funds
General fund
TOTAL FUNDS
Net Current
Assets
31.12.25
Net Current
Assets
31.12.24
£
£
378,671
474,616
378,671
474,616

Page 16

Action Bladder Cancer UK

Notes to the Financial Statements - continued

for the Year Ended 31 December 2025

13. RELATED PARTY DISCLOSURES

Trustees' travel expenses paid for the year ended 31 December 2025 totaled £401 (2024: £nil paid to no Trustees). Speaker fees amounting to £256 were paid to one Trustee in the year (2024: £500).

There were no other related party transactions during the year. (2024: none).

14. CONTROL

The charity is controlled by its board of Trustees.

15 . POST BALANCE SHEET EVENTS

The trustees have considered any events occurring after the balance sheet date and confirm there are no material adjustments or disclosures to make to these financial statements.

16 . CONTINGENT LIABILITIES

The charity had no contingent liabilities at the balance sheet date or in the prior year.

Page 17

Action Bladder Cancer UK Detailed Statement of Financial Activities for the Year Ended 31 December 2025

Income
Donations
Gift Aid
Legacies
Activities for generating funds
Sponsorship
Fundraising events
Interest received
Total income
EXPENDITURE
Costs of generating funds
Costs of generating voluntary income
Costs of generating sponsorship income
Costs of fundraising events
Charitable activities
Educating the public/awareness raising
Patient support
Improving outcomes
Governance costs
Accountancy and book-keeping
Incidental expenses
Independent examination
Secretariat
Insurance
Total expenditure
Net (expenditure)/income
Year Ended
Year Ended
31.12.25
31.12.24
£
£
101,576
170,107
12,653
11,132
11,000
105,000
-
-
47,306
2,539
52,612
2,463
175,074
341,314
4,131
3,152
11,922
9,096
3,653
10,265
19,706
22,513
74,240
63,570
130,002
125,868
36,577
49,888
240,819
239,326
2,872
1,658
284
314
1,746
1,116
5,153
2,538
439
396
10,494
6,022
271,019
267,861
(95,945)
73,453

This page does not form part of the statutory financial statements

Page 18

ACTION BLADDER CANCER UK

Woodlands Grange Woodlands Lane Bradley Stoke Bristol BS32 4JY

September 2026

Dear Sirs & Madams

ACTION BLADDER CANCER UK INDEPENDENT EXAMINATION FOR THE YEAR ENDED 31 December 2025

This representation letter is provided in connection with your independent examination of the financial statements of the charity for the 31 December 2025 Charities Act 2011 requirements.

We confirm that the following representations are made on the basis of enquiries of the trustees, management and staff with relevant knowledge and experience (and, where appropriate, of inspection of supporting documentation) sufficient to satisfy ourselves that we can properly make each of the following representations to you:

REPRESENTATION

ACTION BLADDER CANCER UK CHARITY NUMBER 1164374

6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ

None

None

We confirm that the related party relationships and transactions set out below are a complete list of such relationships and transactions and that we are not aware of any further related parties or transactions.

----- Start of picture text -----
Party Relationship Nature of transaction
ROGER KOCKELBERGH Chair None
Jenny Akins Trustee Expense claim for Speaker fee
Alexandra Colquhoun Trustee None
Caroline Raw Trustee None
DR Peter Harper FRCP Trustee None
Dr MARK PAGE Trustee None
Rik Bryan Trustee None
Allen Knight Trustee None
Paula Allchorne Trustee Expense claim for travel
JEREMY PAUL CREW Trustee None
Joanna Knight Spouse of Allen None
Ben Knight Son of Allen None
John Knight Brother of Allen None
James Akins Spouse of Jenny None
----- End of picture text -----

ACTION BLADDER CANCER UK CHARITY NUMBER 1164374

6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ

----- Start of picture text -----
Oliver Akins Child of Jenny None
Royal Life Saving Society Jenny is a member None
University of Birmingham Rik has current or previous None
employment
Cystotech ApS Denmark Rik is a consultant None
Nonacus Ltd UK Rik is a consultant None
Grande Prive Ltd Rik is founder and chairman None
The Urology Foundation Rik is co-founder None
National Bladder Cancer
Patient Group
Lisa Ryan Spouse of Rik None
Baron Davenports Charity Lisa Bryan is chairman None
American Society of Clinical Peter has None
Oncology membership/interest
Amsurg International Peter holds more that 5% None
share capital
Halcyon Days Holdings Peter holds more that 5% None
share capital
Karen Page Spouse of Mark Page None
Jonathan Raw Spouse of Caroline None
Pauline Tinker Mother of Caroline None
Kane Child of Caroline None
Oxford University Hospitals Jeremy Crew has None
Trust current/previous employment
Oxford University Urology Jeremy Crew is Director None
Specialist Ltd
Angela Wife of Jeremy None
Alexander Crew Child of Jeremy None
Amelia Crew Child of Jeremy None
----- End of picture text -----

ACTION BLADDER CANCER UK

CHARITY NUMBER 1164374

6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ

Other than these matters, we are not aware of any actual or possible instances of noncompliance with laws or regulations whose effects should be considered when preparing financial statements of the charity.

We have disclosed to you all (if any) deficiencies in internal control of which we are aware.

Yours faithfully

ACTION BLADDER CANCER UK CHARITY NUMBER 1164374

6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ

For and behalf of the board of trustees

ACTION BLADDER CANCER UK CHARITY NUMBER 1164374 6 TRULL FARM BUILDINGS, TETBURY, GLOUCESTERSHIRE, GL8 8SQ

ACT15B/DC/UMM September 2026

The Trustees Action Bladder Cancer UK 6 Trull Farm Buildings Tetbury Gloucestershire GL8 8SQ

Dear Sirs

ACTION BLADDER CANCER UK YEAR ENDED 31 DECEMBER 2025

In accordance with our normal practice we are writing to draw your attention to various matters which arose during the course of our independent examination of the charity's accounts for the year ended 31 December 2025.

1.

We have no comments to make concerning the qualitative aspects of the entity's accounting practices and financial reporting.

We did not encounter any significant difficulties during the independent examination, and there are no significant findings to draw to your attention.

2. Letter of representation

A draft of our proposed letter of representation is attached.

In all respects, the letter is routine.

3. Adjusted and unadjusted misstatements

There have been no unadjusted misstatements determined during the course of our independent examination (except for those considered to be clearly trivial).

4.

We propose an unmodified

.

5. Material weaknesses in the accounting and internal control systems

During the course of an independent examination, we do not test your systems and controls, however if we encounter any material deficiencies, we will report them to you.

We noted no material deficiencies to the systems and controls.

6. Other matters to be communicated

There are no other matters to communicate to you.

7. Other relevant matters

Directors: M Dobbins FCA M Dunkley FCA J Weston ACCA CTA L White FCCA Client Partners: F Davey

is the trading name of Dunkley & Co Ltd. VAT No. 927 518 209. Company Number: 2994930. Registered office: Woodlands Grange, Woodlands Lane, Bradley Stoke, Bristol, BS32 4JY. Registered in England. Registered to carry on audit work in the UK, regulated for a range of investment business activities, and licensed to carry out the reserved legal activity of non-contentious probate in England and Wales by the Institute of Chartered Accountants in England & Wales

We have complied with all relevant ethical requirements concerning independence.

We would like to take this opportunity of expressing our thanks to your staff for their assistance during the course of our independent examination.

Please note that this report has been prepared for the sole use of Action Bladder Cancer UK. It must not be disclosed to third parties, quoted or referred to, without our prior written consent. No responsibility is assumed by us to any other person.

If we can be of any further assistance, please contact Daniel Chapman.

Yours faithfully